MART-1(51-73)

MART-1(51-73) is a synthetic peptide fragment derived from the melanoma antigen recognized by T cells 1 (MART-1), a protein commonly expressed in melanocytic cells and frequently studied in immunological and oncological research. As a defined epitope corresponding to amino acid residues 51 through 73 of MART-1, this peptide is of particular interest for its role in antigen presentation and T cell recognition, making it highly relevant to investigations into tumor immunology, antigen processing, and immune monitoring. The molecular characteristics of MART-1(51-73) enable its use in a variety of experimental settings, supporting the elucidation of immune responses against melanoma and the development of novel immunological assays.

Epitope mapping: MART-1(51-73) serves as a valuable tool for mapping T cell epitopes within the MART-1 protein. Researchers employ this peptide to identify and characterize the specific regions recognized by cytotoxic and helper T lymphocytes, thereby advancing the understanding of antigen-specific immune responses in melanoma. Such studies inform the design of immunological assays and facilitate the selection of optimal epitopes for further immunogenicity testing.

Immunological assay development: The peptide is widely utilized in the development and optimization of immunoassays, including enzyme-linked immunospot (ELISpot) and flow cytometry-based assays. By incorporating MART-1(51-73) as a defined antigenic stimulus, investigators can monitor the frequency and functional properties of antigen-specific T cells in peripheral blood or tissue samples. This enables the quantitative assessment of immune responses in preclinical models and ex vivo human samples, providing critical data for immunological research.

Antigen processing studies: As a well-characterized peptide epitope, MART-1(51-73) is instrumental in dissecting the mechanisms of antigen processing and presentation by major histocompatibility complex (MHC) molecules. Researchers use the peptide to evaluate the efficiency of peptide loading onto MHC class II molecules, study peptide-MHC stability, and analyze the requirements for antigen presentation to CD4+ T cells. These insights contribute to a deeper understanding of immune recognition and tolerance mechanisms.

T cell functional analysis: The sequence-specific properties of MART-1(51-73) allow for the selective activation and expansion of MART-1-reactive T cell populations in vitro. Scientists utilize this peptide to stimulate peripheral blood mononuclear cells (PBMCs) or isolated T cell clones, enabling functional studies such as cytokine profiling, proliferation assays, and cytotoxicity assessments. Such applications are crucial for characterizing the quality and specificity of immune responses in melanoma research.

Peptide-based vaccine research: MART-1(51-73) is frequently incorporated into experimental protocols aimed at evaluating the immunogenicity and efficacy of peptide-based vaccines in preclinical settings. By serving as a model antigen, it assists in the assessment of vaccine delivery systems, adjuvant formulations, and immune activation strategies. The use of this peptide in vaccine research provides foundational data that support the rational design of next-generation immunotherapeutic approaches targeting melanoma-associated antigens.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. Cationic cell-penetrating peptides are potent furin inhibitors